Revealing progesterone's role in uterine and mammary gland biology: Insights from the mouse

Seminars in Reproductive Medicine

Volumn 23, Issue 1, 2005, Pages 22-37

  Fernandez Valdivia, Rodrigo ^a   Mukherjee, Atish ^a   Mulac Jericevic, Biserka ^a   Conneely, Orla M ^a   DeMayo, Francesco J ^a   Amato, Paula ^a   Lydon, John P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Isoforms; Mammary gland; Mouse; Progesterone receptor; Uterus

Indexed keywords

AMPHIREGULIN; CALCITONIN; ESTROGEN; HISTIDINE DECARBOXYLASE; LACTOFERRIN; PROGESTERONE;

AMINO TERMINAL SEQUENCE; CANCER SUSCEPTIBILITY; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; DECIDUALIZATION; DEVELOPMENT; DIMERIZATION; DRUG TARGETING; FERTILITY; GENE TARGETING; GENOTYPE; HYPERPLASIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFERTILITY; KNOCKOUT MOUSE; MAMMARY GLAND; MOLECULAR MECHANICS; MORPHOGENESIS; NONHUMAN; PHENOTYPE; PLEIOTROPY; REPRODUCTION; REVIEW; TUMOR GROWTH; UTERUS;

ANIMALS; FEMALE; MAMMARY GLANDS, ANIMAL; MICE; PROGESTERONE; UTERUS;

EID: 14744301796     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-864031     Document Type: Review

References (135)

1. Allen WM. Physiology of the corpus luteum V. Am J Physiol 1930;92:174-188
2. Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol 1961;3:318-356
3. Jensen EV, Suzuki T, Kawashima T, et al. A two-step mechanism for the interaction of estradiol with rat uterus. Proc Nat Acad Sci USA 1969;59:632-638
4. O'Malley BW, McGuire WL, Kohler PO, Korenman SG. Studies on the mechanism of steroid hormone regulation of synthesis of specific proteins. Recent Prog Horm Res 1969;25:105-160
5. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994;63:451-486
6. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839
7. Sartorius CA, Melville MY, Hovland AR, et al. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 1994;8:1347-1360
8. Bain DL, Franden MA, McManaman JL, Takimoto GS, Horwitz KB. The N-terminal region of human progesterone B-receptors: biophysical and biochemical comparison to A-receptors. J Biol Chem 2001;276:23825-23831
9. Tung L, Shen T, Abel MG, et al. Mapping the unique activation function 3 in the progesterone B-receptor upstream segment. Two LXXLL motifs and a tryptophan residue are required for activity. J Biol Chem 2001;276:39843-39851
10. Takimoto GS, Tung L, Abdel-Hafiz H, et al. Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure. J Steroid Biochem Mol Biol 2003;85:209-219
11. Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995;270:1354-1357
12. Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996;85:403-414
13. Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 2000;20:3102-3115
14. Giangrande PH, Pollio G, McDonnell DP. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. J Biol Chem 1997;272:32889-32900
15. Hovland AR, Powell RL, Takimoto GS, Tung L, Horwitz KB. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem 1998;273:5455-5460
16. Schrader WT, O'Malley BW. Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits. J Biol Chem 1972;247:51-59
17. Horwitz KB, Alexander PS. In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 1983;113:2195-2201
18. Soyal SM, Ismail PM, Li J, DeMayo FJ, Lydon JP. Genomic organization and comparative analysis of the murine progesterone receptor gene. Paper presented at the 84th Meeting of the Endocrine Society; June 19-22, 2002; San Francisco, CA
19. Conneely OM, Maxwell BL, Toft DO, Schrader WT, O'Malley BW. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem Biophys Res Commun 1987;149:493-501
20. Kastner P, Krust A, Turcotte B, et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990;9:1603-1614
21. Tora L, Gronemeyer H, Turcotte B, Gaub MP, Chambon P. The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 1988;333:185-188
22. Meyer ME, Quirin-Stricker C, Lerouge T, Bocquel MT, Gronemeyer H. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J Biol Chem 1992;267:10882-10887
23. Vegeto E, Shahbaz MM, Wen DX, et al. Human progesterone receptor A form is a cell and promoter specific repressor of human progesterone receptor B function. Mol Endocrinol 1993;7:1244-1255
24. Sartorius CA, Tung L, Takimoto GS, Horwitz KB. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J Biol Chem 1993;268:9262-9266
25. Mangal RK, Wiehle RD, Poindexter AN III, Weigel NL. Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle. J Steroid Biochem Mol Biol 1997;63:195-202
26. Mote PA, Johnston JF, Manninen T, Tuohimaa P, Clarke CL. Detection of progesterone receptor forms A and B by immunohistochemical analysis. J Clin Pathol 2001;54:624-630
27. Mote PA, Balleine RL, McGowan EM, Clarke CL. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum Reprod 2000;15(suppl 3):48-56
28. Arnett-Mansfield RL, deFazio A, Wain GV, et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res 2001;61:4576-4582
29. Ismail PM, Li J, DeMayo FJ, O'Malley BW, Lydon JP. A novel lacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. Mol Endocrinol 2002;16:2475-2489
30. Hewitt SC, Korach KS. Estrogen receptors: structure, mechanisms and function. Rev Endocr Metab Disord 2002;3:193-200
31. Lydon JP, DeMayo FJ, Funk CR, et al. Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities. Genes Dev 1995;9:2266-2278
32. Lydon JP, DeMayo FJ, Conneely OM, O'Malley BW. Reproductive phenotypes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 1996;56:67-77
33. Mani SK, Allen JM, Lydon JP, et al. Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol Endocrinol 1996;10:1728-1737
34. Chappell PE, Lydon JP, Conneely OM, O'Malley BW, Levine JE. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. Endocrinology 1997;138:4147-4152
35. Phelps SM, Lydon JP, O'Malley BW, Crews D. Regulation of male sexual behavior by progesterone receptor, sexual experience, and androgen. Horm Behav 1998;34:294-302
36. Chappell PE, Schneider JS, Kim P, et al. Absence of gonadotropin surges and gonadotropin-releasing hormone self-priming in ovariectomized (OVX), estrogen (E2)-treated, progesterone receptor knockout (PRKO) mice. Endocrinology 1999;140:3653-3658
37. Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 1999; 59:4276-4284
38. Robker RL, Russell DL, Espey LL, et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci USA 2000;97:4689-4694
39. Soyal S, Ismail PM, Li J, et al. Progesterone receptors - animal models and cell signaling in breast cancer: progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res 2002;4:191-196
40. Ismail PM, Amato P, Soyal SM, et al. Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 2003;68:779-787
41. Eddy EM, Washburn TF, Bunch DO, et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 1996;137:4796-4805
42. Schneider JS, Stone MK, Wynne-Edwards KE, et al. Progesterone receptors mediate male aggression toward infants. Proc Natl Acad Sci USA 2003;100:2951-2956
43. Lydon JP, Soyal S, O'Malley BW, Ismail PM. The progesterone receptor knockout mouse model: new insights into progesterone action in vivo. In: Matzuk MM, Brown CW, Kumar TR, eds. Contemporary Endocrinology: Transgenics in Endocrinology. Totowa, NJ: Humana Press; 2000:173-204
44. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 2000;289:1751-1754
45. Conneely OM, Lydon JP. Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids 2000;65:571-577
46. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 2003;100:9744-9749
47. Conneely OM, Mulac-Jericevic B, Lydon JP. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 2003;68:771-778
48. Picard F, Wanatabe M, Schoonjans K, et al. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta-cell proliferation. Proc Natl Acad Sci USA 2002;99:15644-15648
49. Tibbetts TA, DeMayo F, Rich S, Conneely OM, O'Malley BW. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci USA 1999;96:12021-12026
50. Vazquez F, Rodriguez-Manzaneque JC, Lydon JP, et al. Progesterone regulates proliferation of endothelial cells. J Biol Chem 1999;274:2185-2192
51. Karas RH, van Eickels M, Lydon JP, et al. A complex role for the progesterone receptor in the response to vascular injury. J Clin Invest 2001;108:611-618
52. Carson DD, Bagchi IC, Dey SK, et al. Embryo implantation. Dev Biol 2000;223:217-237
53. Rinkenberger JL, Cross JC, Werb Z. Molecular genetics of implantation in the mouse. Dev Genet 1997;21:6-20
54. Paria BC, Lim H, Das SK, Reese J, Dey SK. Molecular signaling in uterine receptivity for implantation. Semin Cell Dev Biol 2000;11:67-76
55. Paria BC, Reese J, Das SK, Dey SK. Deciphering the crosstalk of implantation: advances and challenges. Science 2002;296:2185-2188
56. Kurita T, Young P, Brody JR, et al. Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis. Endocrinology 1998;139:4708-4713
57. Parandoosh Z, Crombie DL, Tetzke TA, et al. Progesterone and oestrogen receptors in the decidualized mouse uterus and effects of different types of anti-progesterone treatment. J Reprod Fertil 1995;105:215-220
58. Curtis SW, Clark J, Myers P, Korach KS. Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus. Proc Natl Acad Sci USA 1999;96:3646-3651
59. Paria BC, Tan J, Lubahn DB, Dey SK, Das SK. Uterine decidual response occurs in estrogen receptor-alpha-deficient mice. Endocrinology 1999;140:2704-2710
60. Curtis Hewitt S, Goulding EH, Eddy EM, Korach KS. Studies using the estrogen receptor alpha knockout uterus demonstrate that implantation but not decidualization-associated signaling is estrogen dependent. Biol Reprod 2002;67:1268-1277
61. Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP, O'Malley BW. Reproductive functions of progesterone receptors. Recent Prog Horm Res 2002;57:339-355
62. Das SK, Chakraborty I, Paria BC, et al. Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus. Mol Endocrinol 1995;9:691-705
63. Paria BC, Das N, Das SK, et al. Histidine decarboxylase gene in the mouse uterus is regulated by progesterone and correlates with uterine differentiation for blastocyst implantation. Endocrinology 1998;139:3958-3966
64. Lim H, Ma L, Ma WG, Maas RL, Dey SK. Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol Endocrinol 1999;13:1005-1017
65. Ma L, Benson GV, Lim H, Dey SK, Maas RL. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 1998;197:141-154
66. Ding YQ, Zhu LJ, Bagchi MK, Bagchi IC. Progesterone stimulates calcitonin gene expression in the uterus during implantation. Endocrinology 1994;135:2265-2274
67. Muffly KE, Jin DF, Okulicz WC, Kilpatrick DL. Gonadal steroids regulate proenkephalin gene expression in a tissue-specific manner within the female reproductive system. Mol Endocrinol 1988;2:979-985
68. Chen B, Zhang D, Pollard JW. Progesterone regulation of the mammalian ortholog of methylcitrate dehydratase (immune response gene 1) in the uterine epithelium during implantation through the protein kinase C pathway. Mol Endocrinol 2003;17:2340-2354
69. Cheon YP, Xu X, Bagchi MK, Bagchi IC. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology 2003;144:5623-5630
70. Ismail PM, DeMayo FJ, Amato P, Lydon JP. Progesterone induction of calcitonin expression in the murine mammary gland. J Endocrinol 2004;180:287-295
71. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001;15:3059-3087
72. Takamoto N, Zhao B, Tsai SY, DeMayo FJ. Identification of Indian hedgehog as a progesterone-responsive gene in the murine uterus. Mol Endocrinol 2002;16:2338-2348
73. Tsai SY, Tsai MJ. Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age. Endocr Rev 1997;18:229-240
74. Matsumoto H, Zhao X, Das SK, Hogan BL, Dey SK. Indian hedgehog as a progesterone-responsive factor mediating epithelial-mesenchymal interactions in the mouse uterus. Dev Biol 2002;245:280-290
75. Cheon YP, Li Q, Xu X, et al. A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation. Mol Endocrinol 2002;16:2853-2871
76. Bagchi IC, Cheon YP, Li Q, Bagchi MK. Progesterone receptor-regulated gene networks in implantation. Front Biosci 2003;8:s852-s861
77. Antunes CM, Strolley PD, Rosenshein NB, et al. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med 1979;300:9-13
78. Jick H, Watkins RN, Hunter JR, et al. Replacement estrogens and endometrial cancer. N Engl J Med 1979;300:218-222
79. Shapiro S, Kaufman DW, Slone D, et al. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium. N Engl J Med 1980;303:485-489
80. Herrinton LJ, Weiss NS. Postmenopausal unopposed estrogens. Characteristics of use in relation to the risk of endometrial carcinoma. Ann Epidemiol 1993;3:308-318
81. Beresford SA, Weiss NS, Voigt LF, McKnight B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 1997;349:458-461
82. Montgomery BE, Daum GS, Dunton CJ. Endometrial hyperplasia: a review. Obstet Gynecol Surv 2004;59:368-378
83. Arnett-Mansfield RL, DeFazio A, Mote PA, Clarke CL. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium. J Clin Endocrinol Metab 2004;89:1429-1442
84. Balleine RL, Earls PJ, Webster LR, et al. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma. Int J Gynecol Pathol 2004;23:138-144
85. De Vivo I, Huggins GS, Hankinson SE, et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA 2002;99:12263-12268
86. Cooke PS, Buchanan DL, Young P, et al. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci USA 1997;94:6535-6540
87. Kurita T, Wang YZ, Donjacour AA, et al. Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. Cell Death Differ 2001;8:192-200
88. Kurita T, Lee KJ, Cooke PS, Lydon JP, Cunha GR. Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus. Biol Reprod 2000;62:831-838
89. McLaughlin ME, Jacks T. Progesterone receptor expression in neurofibromas. Cancer Res 2003;63:752-755
90. Brisken C, Park S, Vass T, et al. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA 1998;95:5076-5081
91. Edmonds DK, Lindsay KS, Miller JF, Williamson E, Wood PJ. Early embryonic mortality in women. Fertil Steril 1982;38:447-453
92. Zinaman MJ, Clegg ED, Brown CC, O'Connor J, Selevan SG. Estimates of human fertility and pregnancy loss. Fertil Steril 1996;65:503-509
93. Ellish NJ, Saboda K, O'Connor J, et al. A prospective study of early pregnancy loss. Hum Reprod 1996;11:406-412
94. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999;340:1796-1799
95. Society for Assisted Reproductive Technology, American Society for Reproductive Medicine. Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2004;81:1207-1220
96. Kao LC, Tulac S, Lobo S, et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002;143:2119-2138
97. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-333
98. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333
99. Pike MC, Ross RK. Estrogen-progestin replacement therapy: regulatory action needed. Breast Cancer Res 2002;4:222-223
100. Kuller LH. Commentary: hazards of studying women: the oestrogen/progesterone dilemma. Int J Epidemiol 2004. In press
101. Gorins A. Progestins and risk of breast cancer. Much ado about nothing? Eur J Gynaecol Oncol 2003;24:345-350
102. MacLennan AH. The trials and tribulations of long-term postmenopausal hormone therapy. Obstet Gynecol Surv 2004;59:65-67
103. McPherson K. Where are we now with hormone replacement therapy? It works for symptoms but is not good for future health. BMJ 2004;328:357-358
104. Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 2004;304:1269-1273
105. National Cancer Institute Breast Cancer Progress Review Group. Charting the course: priorities for breast cancer research. 1998. Available at: http://prg.nci.nih.gov/breast/finalreport.html. Accessed June 30, 2004
106. Pevzner P, Tesler G. Human and mouse genomic sequences reveal extensive breakpoint reuse in mammalian evolution. Proc Natl Acad Sci USA 2003;100:7672-7677
107. Cardiff RD, Wagner U, Henninghausen L. Mammary cancer in humans and mice: a tutorial for comparative pathology. Vet Pathol 2001;38:357-358
108. Silberstein GB. Postnatal mammary gland morphogenesis. Microsc Res Tech 2001;52:155-162
109. Medina D, Sivaraman L, Hilsenbeck SG, et al. Mechanisms of hormonal prevention of breast cancer. Ann N Y Acad Sci 2001;952:23-35
110. Sivaraman L, Hilsenbeck SG, Zhong L, et al. Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation. J Endocrinol 2001;171:75-83
111. Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol 2001;15:1993-2009
112. D'Cruz CM, Moody SE, Master SR, et al. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 2002;16:2034-2051
113. Bocchinfuso WP, Korach KS. Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 1997;2:323-334
114. Clarke RB, Howell A, Potten CS, Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 1997;57:4987-4991
115. Russo J, Ao X, Grill C, Russo IH. Pattern of distribution of cells positive for estrogen receptor-a and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 1999;53:217-227
116. Seagroves TN, Lydon JP, Hovey RC, Vonderhaar BK, Rosen JM. C/EBPβ(CCAAT/Enhancer Binding Protein) controls cell fate determination during mammary gland development. Mol Endocrinol 2000;14:359-368
117. Ewan KB, Shyamala G, Ravani SA, et al. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol 2002;160:2081-2093
118. Shyamala G, Schneider W, Schott D. Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology 1990;126:2882-2889
119. -/- mice during pregnancy and lactation is epithelial cell autonomous. Dev Biol 1999;212:1-11
120. Graham JD, Yeates C, Balleine RL, et al. Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 1995;55:5063-5068
121. Mote PA, Bartow S, Tran N, Clarke CL. Loss of coordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 2002;72:163-172
122. Fata JE, Kong YY, Li J, et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000;103:41-50
123. Chatterton RT Jr, Lydon JP, Mehta RG, et al. Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a] anthracene-induced hormone-independent preneoplastic lesions in vitro. Cancer Lett 2002;188:47-52
124. Medina D, Kittrell FS, Shepard A, et al. Hormone dependence in premalignant mammary progression. Cancer Res 2003;63:1067-1072
125. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712
126. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 1993;168:1473-1480
127. Schairer C, Lubin J, Troisi R, et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485-491
128. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328-332
129. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427
130. Jull JW. The effects of oestrogens and progesterone on the chemical induction of mammary cancer in mice of the IF strain. J Path Bact 1954;68:547-559
131. Robinson SP, Jordan VC. Reversal of antitumor effects of tamoxifen by progesterone in the 7, 12-dimethylbenzan-thracene-induced rat mammary carcinoma model. Cancer Res 1987;47:5386-5390
132. Russo IH, Russo J. Progestagens and mammary gland development: differentiation versus carcinogenesis. Acta Endocrinol (Copenh) 1991;125:7-12
133. Aldaz CM, Liao QY, La Bate M, Johnston DA. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis 1996;17:2069-2072
134. Corner GW, Allen WM. Physiology of the corpus luteum II. Am J Physiol 1929;88:326-339
135. DeMayo FJ, Soyal S, Mukherjee A, et al. A novel progesterone receptor CRE knockin mouse: a powerful in vivo platform to chart cell-fate and to evaluate potential effectors in progesterone receptor specific cell-lineages. Paper presented at the Keystone Symposium on Nuclear Receptor Sisters (6), February 28-March 4, 2004; Keystone, CO